Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.16%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +36.53%
#5 RedStone RedStone +28.90%
#6 Humanity Humanity +26.35%
#7 Codatta Codatta +22.55%
#8 Walrus Walrus +19.98%
#9 The Black Bull The Black Bull +17.02%
#10 Enso Enso +16.70%
Coin of the day
EXOD EXOD
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Cellular Goods PLC Cellular Goods PLC

Cellular Goods PLC

CBX
Classement en actions #36861
Cellular Goods PLC, along with its associated companies, specializes in... Cellular Goods PLC, along with its associated companies, specializes in creating and distributing consumer products infused with biosynthetic cannabinoids throughout the United Kingdom. Their portfolio includes cannabinoid-based solutions designed for both skincare applications and oral consumption. These items are available for purchase via traditional retailers, directly to customers through their proprietary website, and across various online platforms. Established in 2018, the organization was originally named Leaf Studios PLC, subsequently adopting the Cellular Goods PLC moniker in September 2020, and maintains its headquarters in London, UK.
Prix de l'action
$0.00447785
Dernière synchronisation: 2024-03-12
Capitalisation boursière
$2.26M
Changement (1 jour)
7.54%
Changement (1 an)
0.00%
Pays
GB
Échange Cellular Goods PLC (CBX)

Catégorie

Healthcare
Bénéfices pour Cellular Goods PLC (CBX)
Bénéfices en 2026 TTM : 0
Selon les derniers rapports financiers de Cellular Goods PLC, les bénéfices actuels de l'entreprise sont de 0. En 2026, l'entreprise a réalisé un bénéfice de 0, égal à celui de 2026 qui était de 0. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Cellular Goods PLC de 2026 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
Pas assez de données pour les dates fournies.
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US